The U.S. Food and Drug Administration approved the use of Sanofi and Regeneron's blockbuster drug Dupixent for patients with ...

GLP-1s exploded seemingly out of nowhere, straining pharmacy plan bottom lines. Psoriasis treatments don't have to follow the ...

The FDA has approved the popular drug Dupixent (generic name, dupilumab) for adults and kids 12 and up with chronic spontaneous urticaria (CSU), a long-lasting itchy skin condition, when regular ...

The FDA had rejected the companies’ initial application in 2023, requesting additional data after the pharma firms reported ...

Patients undergoing treatment with Dupixent may experience notable adverse ... 6 months of age and older with moderate-to-severe eczema (atopic dermatitis or AD) that is not well controlled ...

A school administrator who has been suffering topical steroid withdrawal (TSW) says she feels helpless after five years of ...